
Evelyn Y. Pyla
Examiner (ID: 2124, Phone: (571)270-7366 , Office: P/1651 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 4141, 1651, 1633 |
| Total Applications | 680 |
| Issued Applications | 316 |
| Pending Applications | 95 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17168973
[patent_doc_number] => 20210322643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Methods for Development and Use of Minimally Polarized Function Cell Micro-Aggregate Units in Tissue Applications Using LGR4, LGR5 and LGR6 Expressing Epithelial Stem Cells
[patent_app_type] => utility
[patent_app_number] => 17/326734
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326734 | Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells | May 20, 2021 | Issued |
Array
(
[id] => 20106949
[patent_doc_number] => 12357647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
[patent_app_type] => utility
[patent_app_number] => 17/244437
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4459
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244437 | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | Apr 28, 2021 | Issued |
Array
(
[id] => 18406080
[patent_doc_number] => 20230167431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => TAGGED GENE EDITING TECHNOLOGY FOR CLINICAL CELL SORTING AND ENRICHMENT
[patent_app_type] => utility
[patent_app_number] => 17/997351
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997351 | TAGGED GENE EDITING TECHNOLOGY FOR CLINICAL CELL SORTING AND ENRICHMENT | Apr 27, 2021 | Pending |
Array
(
[id] => 17007396
[patent_doc_number] => 20210238557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => PERSONALIZED CELLS, TISSUES, AND ORGANS FOR TRANSPLANTATION FROM A HUMANIZED, BESPOKE, DESIGNATED-PATHOGEN FREE, (NON-HUMAN) DONOR AND METHODS AND PRODUCTS RELATING TO SAME
[patent_app_type] => utility
[patent_app_number] => 17/237336
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 661
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237336 | Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same | Apr 21, 2021 | Issued |
Array
(
[id] => 17156364
[patent_doc_number] => 20210317415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => PERFUSION SYSTEM FOR HARVESTING BONE MARROW
[patent_app_type] => utility
[patent_app_number] => 17/227217
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227217 | PERFUSION SYSTEM FOR HARVESTING BONE MARROW | Apr 8, 2021 | Abandoned |
Array
(
[id] => 17595668
[patent_doc_number] => 20220145242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => EXTRACELLULAR MATRIX-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, AND THREE-DIMENSIONAL TISSUE CONSTRUCT AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/430648
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430648 | EXTRACELLULAR MATRIX-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, AND THREE-DIMENSIONAL TISSUE CONSTRUCT AND METHOD FOR PRODUCING SAME | Mar 24, 2021 | Abandoned |
Array
(
[id] => 18391739
[patent_doc_number] => 20230159957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/911391
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911391 | COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID | Mar 11, 2021 | Pending |
Array
(
[id] => 16990219
[patent_doc_number] => 20210228639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD OF TREATING THE EFFECTS OF STROKE
[patent_app_type] => utility
[patent_app_number] => 17/194855
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194855
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194855 | METHOD OF TREATING THE EFFECTS OF STROKE | Mar 7, 2021 | Pending |
Array
(
[id] => 20757144
[patent_doc_number] => 12649903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Liver organoid, uses thereof and culture method for obtaining them
[patent_app_type] => utility
[patent_app_number] => 17/191650
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 50
[patent_no_of_words] => 25949
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191650 | Liver organoid, uses thereof and culture method for obtaining them | Mar 2, 2021 | Issued |
Array
(
[id] => 17227272
[patent_doc_number] => 20210353828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => MICROCAPILLARY NETWORK BASED SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 17/185545
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185545 | MICROCAPILLARY NETWORK BASED SCAFFOLD | Feb 24, 2021 | Abandoned |
Array
(
[id] => 20358331
[patent_doc_number] => 12474322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Methods and compositions for reducing antibiotic administration to farm animals
[patent_app_type] => utility
[patent_app_number] => 17/175114
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 6108
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175114 | Methods and compositions for reducing antibiotic administration to farm animals | Feb 11, 2021 | Issued |
Array
(
[id] => 19374884
[patent_doc_number] => 12066445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => System and method for cell levitation and monitoring
[patent_app_type] => utility
[patent_app_number] => 17/169765
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 58
[patent_no_of_words] => 12229
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169765 | System and method for cell levitation and monitoring | Feb 7, 2021 | Issued |
Array
(
[id] => 20328398
[patent_doc_number] => 12458655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
[patent_app_type] => utility
[patent_app_number] => 17/166547
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5342
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166547 | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section | Feb 2, 2021 | Issued |
Array
(
[id] => 18434326
[patent_doc_number] => 20230181620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/795915
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795915 | COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOF | Jan 28, 2021 | Pending |
Array
(
[id] => 20185857
[patent_doc_number] => 12396957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Cell lines and their use in encapsulated cell biodelivery
[patent_app_type] => utility
[patent_app_number] => 17/145877
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 13550
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145877 | Cell lines and their use in encapsulated cell biodelivery | Jan 10, 2021 | Issued |
Array
(
[id] => 18207097
[patent_doc_number] => 20230053353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TARGETING TRANSFER RNA FOR THE SUPPRESSION OF NONSENSE MUTATIONS IN MESSENGER RNA
[patent_app_type] => utility
[patent_app_number] => 17/791498
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791498 | TARGETING TRANSFER RNA FOR THE SUPPRESSION OF NONSENSE MUTATIONS IN MESSENGER RNA | Jan 7, 2021 | Abandoned |
Array
(
[id] => 20593881
[patent_doc_number] => 12577585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Compositions and methods of use of oncolytic virus like vesicles
[patent_app_type] => utility
[patent_app_number] => 17/791873
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 31
[patent_no_of_words] => 10485
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791873 | Compositions and methods of use of oncolytic virus like vesicles | Jan 7, 2021 | Issued |
Array
(
[id] => 16748922
[patent_doc_number] => 20210100931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS FOR STABILIZING A BIOPROSTHETIC TISSUE BY CHEMICAL MODIFICATION OF ANTIGENIC CARBOHYDRATES
[patent_app_type] => utility
[patent_app_number] => 17/127281
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127281 | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates | Dec 17, 2020 | Issued |
Array
(
[id] => 17982893
[patent_doc_number] => 20220348929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/725324
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725324 | CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS | Dec 7, 2020 | Pending |
Array
(
[id] => 20547682
[patent_doc_number] => 12558455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Biologic composition and method of use
[patent_app_type] => utility
[patent_app_number] => 17/114896
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 0
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114896 | Biologic composition and method of use | Dec 7, 2020 | Issued |